問卷

TPIDB > Principal Investigator

Principal Investigator


Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F. (在職)

Division of Hematology & Oncology

Division of Thoracic Medicine

Division of Rheumatology

Division of Radiology

Division of General Internal Medicine

Linkou Chang Gung Medical Foundation (在職)

Division of Hematology & Oncology

Taipei Veterans General Hospital

Division of Hematology & Oncology

更新時間:2023-09-19

李劭軒Li, Shau-Hsuan
  • Principal Investigator
  • Clinical Trial Experience (year) 17 years 10 個月
  • lee056058@gmail.com

  • nana.fen.tw@gmail.com

篩選

List

241Cases

2021-10-01 - 2027-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Not yet recruiting2Sites

Recruiting6Sites

2020-06-26 - 2026-12-31

Phase I/II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting6Sites

2024-11-01 - 2031-06-30

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2015-10-01 - 2020-06-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting3Sites

Terminated3Sites

馮思中
Linkou Chang Gung Medical Foundation

Division of Hematology & Oncology

張牧新
Taipei Veterans General Hospital

Division of Hematology & Oncology

2017-05-01 - 2020-07-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
11Sites

Recruiting2Sites

Terminated8Sites

2021-02-01 - 2026-03-18

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Not yet recruiting2Sites

Recruiting7Sites

Terminated1Sites

2020-10-26 - 2024-10-01

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Recruiting6Sites

Terminated3Sites

2020-09-16 - 2024-01-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting6Sites

2020-01-01 - 2024-12-25

Phase I/II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting4Sites

Terminated1Sites

2021-06-30 - 2023-11-14

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Not yet recruiting3Sites

Recruiting2Sites